DAFNA Capital Management LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$5,023,150
+32.7%
550,784
+53.9%
1.56%
+50.9%
Q2 2023$3,785,355
+181.9%
357,784
+225.9%
1.04%
+156.8%
Q1 2023$1,342,658
-25.3%
109,784
-24.2%
0.40%
-20.4%
Q4 2022$1,796,769
-36.2%
144,784
-29.8%
0.51%
-33.2%
Q3 2022$2,818,000
+30.5%
206,329
+75.1%
0.76%
+28.7%
Q2 2022$2,160,000
+18.6%
117,829
+4.0%
0.59%
+24.0%
Q1 2022$1,822,000
+17.4%
113,329
+2.3%
0.48%
+21.8%
Q4 2021$1,552,000
-17.8%
110,829
+9.9%
0.39%
-22.2%
Q3 2021$1,889,000
+8.4%
100,829
+20.7%
0.50%
+37.6%
Q2 2021$1,742,000
+19.0%
83,529
+61.3%
0.36%
+4.9%
Q1 2021$1,464,000
+398.0%
51,800
+475.6%
0.35%
+298.9%
Q4 2020$294,000
-75.4%
9,000
-76.9%
0.09%
-77.6%
Q3 2020$1,196,000
-75.1%
39,019
-86.7%
0.39%
-71.9%
Q2 2020$4,796,000
+56.7%
294,260
-4.3%
1.38%
+8.4%
Q1 2020$3,060,000
+28.3%
307,541
+77.3%
1.28%
+55.9%
Q4 2019$2,385,000
+51.7%
173,475
+67.4%
0.82%
+38.6%
Q3 2019$1,572,000
+69.0%
103,658
+119.4%
0.59%
+68.9%
Q2 2019$930,000
+53.5%
47,242
+29.2%
0.35%
+34.1%
Q1 2019$606,000
-71.0%
36,558
-75.4%
0.26%
-74.9%
Q4 2018$2,087,000
-50.4%
148,617
-38.2%
1.04%
-39.9%
Q3 2018$4,209,000
-3.4%
240,500
+0.4%
1.73%
-15.3%
Q2 2018$4,359,000
+83.1%
239,500
+88.6%
2.04%
+76.3%
Q1 2018$2,381,000
+32.7%
127,000
+8.3%
1.16%
+19.9%
Q4 2017$1,794,000
+13.3%
117,281
+10.8%
0.97%
-1.7%
Q3 2017$1,583,000105,8590.98%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders